×
For best experience we recommend to activate Javascript in your browser.
Recombinant CTLA4 antibody
The Human Monoclonal anti-CTLA4 antibody (Clone 9D9) (ABIN7795498) specifically detects CTLA4 in FACS.
The antibody is reactive with Mouse samples.
Catalog No. ABIN7795498
$109.52
$128.85
save $19.33 (-15 %)
Plus shipping costs $50.00
Delivery in 11 to 16 Business Days
Quick Overview for Recombinant CTLA4 antibody (ABIN7795498)
Target
See all CTLA4 Antibodies
CTLA4
(Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for CTLA4 antibodies
Mouse
Host
All hosts for CTLA4 antibodies
Human
Clonality
All clonalities for CTLA4 antibodies
Monoclonal
Conjugate
All conjugates for CTLA4 antibodies
This CTLA4 antibody is un-conjugated
Application
All applications for CTLA4 antibodies
Flow Cytometry (FACS)
Clone
9D9
Product Details anti-CTLA4 Antibody
(hide)
Expression System
Mammalian cells
Purpose
Recombinant Anti-mouse CTLA-4 Monoclonal Antibody (Clone: 9D9), Human IgG1 Fc Silent Kappa
Characteristics
The 9D9 antibody blocks the mouse cytotoxic T lymphocyte antigen-4 (CTLA-4). Blocking CTLA-4 removes an inhibitory signal from reducing the activity of T lymphocytes. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) is an inhibitory molecule that competes with the stimulatory CD28 for binding to B7 on antigen presenting cells. CTLA-4 and CD28 are both presented on the surface of T-cells.
Purification
Protein A or G affinity column
Purity
>95 % by reducing SDS-PAGE
Isotype
Fc Silenced, IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
> 3 mg/mL
Storage
4 °C,-20 °C
Storage Comment
Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
Target Details for CTLA4
(hide)
Target
CTLA4
(Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
Alternative Name
CTLA-4
Pathways
Cancer Immune Checkpoints
Recently viewed
(hide)
Chat with us , powered by LiveChat